Replies to post #370324 on Innovation Pharmaceuticals Inc (IPIX)

[cabel]

Were they able to do most of that during the 60 day waiting period while waiting for the last telephone visit?

Most of the data collected till then was fixed and unchanging. Why not use that time.

[Longpicker]

Ok if everything is going by industry and regulatory norms we’re in great shape! Thanks for the reply.

[kfcyahoo]

""The subject database remains blinded with the current emphasis on confirmation of all data entered at study sites, as well as completion of source data verification and the necessary checks and reviews by the data management vendor in preparation of database lock.

Following database lock and transfer to the biostatistics vendor, analysis of the unblinded data from the clinical trial will begin to assess Brilacidin’s performance, against placebo, across primary, secondary, and other endpoints. Topline results are anticipated to be available one week after database lock, with full analysis to follow."

In my mind, the most difficult part of the "decision makers", is culling out all the incoming info and comparing to other released data. This is a dynamic situation, for many.

To date, ipix pronouncements come from the ceo w/o strong/any verbal backup to back-up his forward looking statements.

We all shall see.

Go ipix!